UpdatesPress Release

CORONA Remedies commenced commercial production at its EU-GMP approved Women's Hormone facility.

CORONA Remedies LimitedCORONA · Filed with the exchange

The state-of-the-art plant strengthens manufacturing capabilities for domestic and international markets, expected to boost in-house hormone manufacturing capacity by 20%.

Read the original filing(PDF)

No comments yet. Be the first.

More from CORONA Remedies Limited

All announcements